(Q38177322)

30 August 2017

title

Evidence-based recommendations for successful Helicobacter pylori treatment (English)

1 reference

Helicobacter pylori infectious disease

30 August 2017

0 references

1 reference

3

David Y Graham

1 reference

30 August 2017

Jeng-Yih Wu

1

1 reference

30 August 2017

Jyh-Ming Liou

series ordinal

2

1 reference

30 August 2017

publication date

2 December 2013

1 reference

Expert Review of Gastroenterology & Hepatology

30 August 2017

published in

1 reference

30 August 2017

volume

8

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

21-28

1 reference

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Resistance of Helicobacter pylori to antibiotics and its impact on treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

New concepts of resistance in the treatment of Helicobacter pylori infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Clinical practice. Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Optimal therapy for Helicobacter pylori infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Efficient identification and evaluation of effective Helicobacter pylori therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Relationship between the Acid-Inhibitory Effects of Two Proton Pump Inhibitors and CYP2C19 Genotype in Japanese Subjects: A Randomized Two-Way Crossover Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2014.859522

10.1586/17474124.2014.859522

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference